EXHIBIT 11
DURA PHARMACEUTICALS, INC.
STATEMENTS RE COMPUTATIONS OF NET INCOME PER SHARE
IN THOUSANDS, EXCEPT PER SHARE AMOUNTS
(UNAUDITED)
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
-------------------- -----------------
1997 1998 1997 1998
---------- ------- ------- --------
NET INCOME PER SHARE - BASIC
Net Income ................................................. $ 11,325 $ 2,424 $29,395 $17,765
---------- ------- ------- --------
---------- ------- ------- --------
Weighted Average Number of Common Shares ................... 43,875 46,367 43,633 46,216
---------- ------- ------- --------
---------- ------- ------- --------
Net Income per Share ....................................... $ 0.26 $ 0.05 $ 0.67 $ 0.38
---------- ------- ------- --------
---------- ------- ------- --------
NET INCOME PER SHARE - DILUTED
Net Income ................................................. $ 11,325 $ 2,424 $29,395 $17,765
---------- ------- ------- --------
---------- ------- ------- --------
Weighted Average Number of Common and Common
Equivalent Shares Assuming Issuance of All
Dilutive Contingent Shares:
Common stock ........................................... 43,875 46,367 43,633 46,216
Stock options .......................................... 1,124 482 1,138 602
Warrants ............................................... 2,607 729 2,621 829
---------- ------- ------- -------
Total ............................................... 47,606 47,578 47,392 47,647
---------- ------- ------- --------
---------- ------- ------- --------
Net Income per Share .................................... $ 0.24 $ 0.05 $ 0.62 $ 0.37
---------- ------- ------- --------
---------- ------- ------- --------